November 17, 2022, Tokyo, Japan - Takaaki Hirotsu, founder of Hirotsu Bioscience announces the company develops the pancreatic cancer screening test "N-Nose plus Pancreas" using user's urine in Tokyo on Thursday, November 17, 2022. Hirotsu Bioscience